News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI By Todd Neale August 31, 2024
News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events By Caitlin E. Cox August 31, 2024
News Conference News ESC 2024 No Go for No-Touch SVG Harvesting in CABG Surgery: SWEDEGRAFT By Michael O'Riordan August 31, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER By Todd Neale August 31, 2024
News Conference News ESC 2024 New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day By Yael L. Maxwell August 31, 2024
News Conference News ESC 2024 Polypills Show Promise in Diverse Hypertensive Patient Groups By L.A. McKeown August 31, 2024
News Conference News ESC 2024 RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board By Shelley Wood August 31, 2024
News Conference News ESC 2024 Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery By Todd Neale August 30, 2024
News Conference News ESC 2024 ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients By Michael O'Riordan August 30, 2024
News Conference News ESC 2024 HELIOS-B: Novel ‘Silencer’ Agent Reduces Death, CV Events in ATTR-CM By L.A. McKeown August 30, 2024